Last update:

Ophthalmology news

A 15-minute VR eye test could flag vision changes tied to brain health

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality (VR) headset.

Nearly half of people facing cataract-related blindness still need surgery

The World Health Organization (WHO) has called on countries to improve their global cataract care, after new findings suggest that millions of people living with cataract still do not have access to simple, sight-restoring ...

Eye cancer genes predetermine liver metastasis, study finds

Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more effectively treat the cancer and ...

Decoding the molecular signatures of night blindness

Congenital stationary night blindness (CSNB) is caused by mutations in a specific calcium channel. A comprehensive proteomic study by researchers at the University of Innsbruck now reveals how these mutations trigger complex, ...

Eye drops may affect liver cells

A chemical used in some over-the-counter eye drops may affect liver cells and be transformed to a PFAS-like substance. This is according to a new study from Örebro University published in Environment International. "We initiated ...

Eye scan can reveal risk of having a heart attack or stroke

A simple digital photograph of the back of the eye can predict a major cardiovascular event—such as a heart attack or stroke—set to happen in the next decade with 70% accuracy, according to research supported by the British ...

Cancer drug shows promise as treatment for blindness

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness ...

NRTI use linked to risk for primary open-angle glaucoma

Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG), according to a study published online June 20 in Ophthalmology.